Nyxoah S A (NYXH)

$1.54 +0.04 (2.67%)
Market Cap 58.14M
Revenue (ttm) 11.34M
Net Income (ttm) -101.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -898.77%
Debt to Equity Ratio 0.70
Volume 179,400
Avg Vol 323,424
Day's Range N/A - N/A
Shares Out 38.76M
Stochastic %K 19%
Beta 1.63
Analysts Sell
Price Target $3.75

Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Devices
Sector: Healthcare
Phone: 32 1 045 90 75
Fax: 32 1 045 90 75
Address:
Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
Noobnr1
Noobnr1 Sep. 8 at 11:59 AM
$BEAM 🙏🚀🙏🚀 Next launches for $NYXH $PHAR and $OMER 🤞🤞
0 · Reply
Invescent
Invescent Sep. 8 at 6:05 AM
Small Cap Catalysts Reported Over the Break $FFAI Catalyst: Fresh Monday night update with record August robotics sales/shipments, positive product-level gross margins and continued debt reduction. Price: ~$1.85 Float: ~3.79M Short Float: ~19% Market Cap: ~$7M Very small float + fresh holiday catalyst + decent short interest. Watching closely for volume confirmation today. $NYXH Catalyst: First U.S. patient implanted in the BREATHE post-approval study, announced Monday while markets were closed. Price: ~$1.62 Float: ~50.9M Short Float: ~0.9%
0 · Reply
focafoca99
focafoca99 Sep. 7 at 11:16 PM
$NYXH announced its first patient implanted in the U.S. BREATHE study of the Genio system.
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 7 at 9:53 PM
$NYXH Larger float here... Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System "today announced that the first patient has been implanted in BREATHE, the Company’s U.S. post-approval study of the Genio® system."
0 · Reply
Noobnr1
Noobnr1 Sep. 6 at 5:30 AM
$NYXH Hello we are so underrated, helping lots of people for a better sleep. Going to be a huge business, expanding well $GILD $PFE $OMER
0 · Reply
Lilingpeace
Lilingpeace Sep. 3 at 10:06 PM
$NYXH Gemini says:
0 · Reply
topstockalerts
topstockalerts Sep. 3 at 8:44 PM
Nyxoah SA said its pivotal U.S. ACCCESS study met its primary safety and efficacy endpoints in patients with Complete Concentric Collapse. The medtech company reported a 77.2% Apnea-Hypopnea Index response rate and no serious device-related adverse events over 12 months. The Genio system was evaluated in patients with Complete Concentric Collapse of the soft palate, a population currently contraindicated for commercially available unilateral hypoglossal nerve stimulation in the U.S. At 12 months, the study showed a 77.2% AHI response rate, meeting Sher criteria, while the Oxygen Desaturation Index response rate reached 78.7%. The primary analysis included 47 patients who were implanted, activated and completed at least one sleep study. Enrollment was completed in August 2025 ahead of the planned maximum of 106 patients. $NYXH
0 · Reply
topstockalerts
topstockalerts Sep. 3 at 2:17 PM
Top Gainers PT2 $AEHL $BIAF $SNOW $NYXH $LHAI
0 · Reply
GTMStox
GTMStox Sep. 3 at 2:04 PM
$NYXH Grade A POS
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Sep. 3 at 1:20 PM
🌅 Watchlist part 2 ✅ $TLYS low 5 support, above 5.30, potential to 5.60/.80 ✅ $NYXH 1.80 support, ideal if above 2; above 2.10, potential to 2.50/.60 ✅ $UFG .60 support, above .80, potential to 1/1.30 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $CAST $FRTT still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
Latest News on NYXH
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

Mon, 07 Sep 2026 16:05:00 -0400 - 5 days ago

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

Nyxoah announces ACCESS study meets primary safety, efficacy endpoints

2026-09-02T20:30:20.000Z - 10 days ago

Nyxoah announces ACCESS study meets primary safety, efficacy endpoints

Nyxoah price target lowered to $6 from $11 at Cantor Fitzgerald

2026-08-17T12:20:19.000Z - 26 days ago

Nyxoah price target lowered to $6 from $11 at Cantor Fitzgerald

Nyxoah price target lowered to $2.31 from $2.86 at Baird

2026-08-06T13:38:52.000Z - 5 weeks ago

Nyxoah price target lowered to $2.31 from $2.86 at Baird

Nyxoah price target lowered to $6 from $7 at Piper Sandler

2026-08-06T13:06:15.000Z - 5 weeks ago

Nyxoah price target lowered to $6 from $7 at Piper Sandler

Nyxoah price target lowered to $4 from $13 at Oppenheimer

2026-08-06T12:26:09.000Z - 5 weeks ago

Nyxoah price target lowered to $4 from $13 at Oppenheimer

Nyxoah Q2 Earnings Call Highlights

Wed, 05 Aug 2026 23:04:18 -0400 - 5 weeks ago

Nyxoah Q2 Earnings Call Highlights

Nyxoah Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 5 weeks ago

Nyxoah Earnings Call Transcript: Q2 2026

Nyxoah Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 5 weeks ago

Nyxoah Earnings release: Q2 2026

Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results

Wed, 05 Aug 2026 16:05:00 -0400 - 5 weeks ago

Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results

Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026

Mon, 27 Jul 2026 16:05:00 -0400 - 6 weeks ago

Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026

Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day

Fri, 10 Jul 2026 19:02:52 -0400 - 2 months ago

Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day

Nyxoah price target lowered to $2.85 from $4 at Baird

2026-07-09T10:20:21.000Z - 2 months ago

Nyxoah price target lowered to $2.85 from $4 at Baird

Nyxoah Transcript: CMD 2026

Jul 8, 2026, 10:00 AM EDT - 2 months ago

Nyxoah Transcript: CMD 2026

Nyxoah sees Q2 revenue EUR 7.7M

2026-07-07T20:15:51.000Z - 2 months ago

Nyxoah sees Q2 revenue EUR 7.7M

Nyxoah backs FY26 revenue view EUR 36M-EUR 40M

2026-07-07T20:15:29.000Z - 2 months ago

Nyxoah backs FY26 revenue view EUR 36M-EUR 40M

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

Tue, 07 Jul 2026 16:05:00 -0400 - 2 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

Information on the total number of voting rights and shares

Tue, 30 Jun 2026 16:30:00 -0400 - 2 months ago

Information on the total number of voting rights and shares

Publication relating to transparency notifications

Mon, 29 Jun 2026 16:30:00 -0400 - 2 months ago

Publication relating to transparency notifications

Nyxoah to Host Investor Day in New York on July 8, 2026

Tue, 23 Jun 2026 16:05:00 -0400 - 2 months ago

Nyxoah to Host Investor Day in New York on July 8, 2026

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026

Fri, 19 Jun 2026 16:30:00 -0400 - 2 months ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026

Publication relating to transparency notifications

Wed, 17 Jun 2026 16:30:00 -0400 - 2 months ago

Publication relating to transparency notifications

Nyxoah Receives $15 Million from the European Investment Bank

Wed, 17 Jun 2026 16:05:00 -0400 - 2 months ago

Nyxoah Receives $15 Million from the European Investment Bank

Nyxoah price target lowered to $3 from $5 at Stifel

2026-06-17T10:55:08.000Z - 2 months ago

Nyxoah price target lowered to $3 from $5 at Stifel

Information on the total number of voting rights and shares

Wed, 10 Jun 2026 17:00:00 -0400 - 3 months ago

Information on the total number of voting rights and shares

$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch

Wed, 10 Jun 2026 16:30:00 -0400 - 3 months ago

$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch

Nyxoah Announces Closing of Underwritten Public Offering

Wed, 10 Jun 2026 16:05:00 -0400 - 3 months ago

Nyxoah Announces Closing of Underwritten Public Offering

Nyxoah S.A. trading resumes

2026-06-05T15:45:09.000Z - 3 months ago

Nyxoah S.A. trading resumes

Nyxoah 55.23M share Spot Secondary priced at $1.72

2026-06-05T15:36:10.000Z - 3 months ago

Nyxoah 55.23M share Spot Secondary priced at $1.72

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

Fri, 05 Jun 2026 11:25:00 -0400 - 3 months ago

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

Nyxoah S.A. trading halted, news pending

2026-06-05T13:57:42.000Z - 3 months ago

Nyxoah S.A. trading halted, news pending

Nyxoah announces offering of ordinary shares, no amount given

2026-06-04T20:14:55.000Z - 3 months ago

Nyxoah announces offering of ordinary shares, no amount given

Nyxoah announces plan to transition to U.S.-based CEO

2026-06-04T20:05:10.000Z - 3 months ago

Nyxoah announces plan to transition to U.S.-based CEO

Nyxoah Announces Proposed Offering of Ordinary Shares

Thu, 04 Jun 2026 16:02:00 -0400 - 3 months ago

Nyxoah Announces Proposed Offering of Ordinary Shares

Nyxoah Enters New Chapter of Long Term Value Creation

Thu, 04 Jun 2026 16:01:00 -0400 - 3 months ago

Nyxoah Enters New Chapter of Long Term Value Creation

Nyxoah Slides: Corporate presentation

May 26, 2026, 7:00 AM EDT - 3 months ago

Nyxoah Slides: Corporate presentation

Information on the total number of voting rights and shares

Wed, 20 May 2026 16:30:00 -0400 - 3 months ago

Information on the total number of voting rights and shares

Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum

Wed, 20 May 2026 16:05:00 -0400 - 3 months ago

Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum

Nyxoah Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 8:15 PM EDT - 4 months ago

Nyxoah Transcript: Bank of America Global Healthcare Conference 2026

Nyxoah price target lowered to $7 from $9 at Piper Sandler

2026-05-13T11:14:11.000Z - 4 months ago

Nyxoah price target lowered to $7 from $9 at Piper Sandler

Nyxoah Q1 Earnings Call Highlights

Tue, 12 May 2026 21:09:14 -0400 - 4 months ago

Nyxoah Q1 Earnings Call Highlights

Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year

2026-05-12T22:33:58.000Z - 4 months ago

Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year

Nyxoah Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 4 months ago

Nyxoah Earnings Call Transcript: Q1 2026

Nyxoah Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 4 months ago

Nyxoah Earnings release: Q1 2026

Nyxoah Reports First Quarter 2026 Financial and Operating Results

Tue, 12 May 2026 16:05:00 -0400 - 4 months ago

Nyxoah Reports First Quarter 2026 Financial and Operating Results

Nyxoah downgraded to Hold from Buy at Stifel

2026-05-12T01:45:10.000Z - 4 months ago

Nyxoah downgraded to Hold from Buy at Stifel

INSP

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

Tue, 28 Apr 2026 16:05:00 -0400 - 4 months ago

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

Nyxoah price target lowered to $8 from $10 at Stifel

2026-04-10T11:45:49.000Z - 5 months ago

Nyxoah price target lowered to $8 from $10 at Stifel

Nyxoah price target lowered to $4.62 from $5.87 at Baird

2026-03-23T10:36:07.000Z - 5 months ago

Nyxoah price target lowered to $4.62 from $5.87 at Baird

Publication relating to transparency notifications

Fri, 20 Mar 2026 17:30:00 -0400 - 5 months ago

Publication relating to transparency notifications

Nyxoah price target lowered to $10 from $11 at Stifel

2026-03-20T11:45:13.000Z - 5 months ago

Nyxoah price target lowered to $10 from $11 at Stifel

Nyxoah Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Nyxoah Earnings Call Transcript: Q4 2025

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Nyxoah Annual report: Q4 2025

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Nyxoah Annual report: Q4 2025

Nyxoah Earnings release: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Nyxoah Earnings release: Q4 2025

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Thu, 19 Mar 2026 16:10:00 -0400 - 5 months ago

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 16, 2026, 8:40 AM EDT - 6 months ago

Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Publication relating to transparency notification

Fri, 13 Mar 2026 17:30:00 -0400 - 6 months ago

Publication relating to transparency notification

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Wed, 11 Mar 2026 17:05:00 -0400 - 6 months ago

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Thu, 05 Mar 2026 16:05:00 -0500 - 6 months ago

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Wed, 18 Feb 2026 16:05:00 -0500 - 6 months ago

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Wed, 21 Jan 2026 16:05:00 -0500 - 7 months ago

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Nyxoah Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 15, 2026, 3:00 PM EST - 8 months ago

Nyxoah Transcript: 44th Annual J.P. Morgan Healthcare Conference

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Dec 19, 2025, 4:05 PM EST - 8 months ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Dec 17, 2025, 1:05 AM EST - 8 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Nyxoah Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 4, 2025, 1:30 PM EST - 9 months ago

Nyxoah Transcript: Piper Sandler 37th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 27, 2025, 4:05 PM EST - 9 months ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nov 26, 2025, 1:45 AM EST - 9 months ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:36 PM EST - 10 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nyxoah Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Nyxoah Earnings Call Transcript: Q3 2025

Nyxoah Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Nyxoah Earnings release: Q3 2025

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 13, 2025, 4:12 PM EST - 10 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nyxoah Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 9:20 AM EST - 10 months ago

Nyxoah Transcript: Stifel 2025 Healthcare Conference

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 10 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 30, 2025, 5:10 PM EDT - 10 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Oct 6, 2025, 1:00 AM EDT - 11 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 23, 2025, 4:10 PM EDT - 11 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 15, 2025, 4:10 PM EDT - 12 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Nyxoah Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 5:35 PM EDT - 1 year ago

Nyxoah Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Nyxoah Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 11:30 AM EDT - 1 year ago

Nyxoah Transcript: Cantor Global Healthcare Conference 2025

Nyxoah Announces Upcoming Investor Events

Sep 2, 2025, 4:30 PM EDT - 1 year ago

Nyxoah Announces Upcoming Investor Events

Nyxoah Earnings Call Transcript: Q2 2025

Aug 18, 2025, 4:30 PM EDT - 1 year ago

Nyxoah Earnings Call Transcript: Q2 2025

Nyxoah Earnings release: Q2 2025

Aug 18, 2025, 4:30 PM EDT - 1 year ago

Nyxoah Earnings release: Q2 2025

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 18, 2025, 4:10 PM EDT - 1 year ago

Nyxoah Reports Second Quarter Financial and Operating Results

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 11, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Aug 8, 2025, 4:10 PM EDT - 1 year ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 29, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jul 28, 2025, 4:05 PM EDT - 1 year ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Jun 13, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

Nyxoah Earnings Call Transcript: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings Call Transcript: Q1 2025

Nyxoah Earnings release: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings release: Q1 2025

Nyxoah Reports First Quarter Financial and Operating Results

May 14, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Reports First Quarter Financial and Operating Results

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

May 9, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Noobnr1
Noobnr1 Sep. 8 at 11:59 AM
$BEAM 🙏🚀🙏🚀 Next launches for $NYXH $PHAR and $OMER 🤞🤞
0 · Reply
Invescent
Invescent Sep. 8 at 6:05 AM
Small Cap Catalysts Reported Over the Break $FFAI Catalyst: Fresh Monday night update with record August robotics sales/shipments, positive product-level gross margins and continued debt reduction. Price: ~$1.85 Float: ~3.79M Short Float: ~19% Market Cap: ~$7M Very small float + fresh holiday catalyst + decent short interest. Watching closely for volume confirmation today. $NYXH Catalyst: First U.S. patient implanted in the BREATHE post-approval study, announced Monday while markets were closed. Price: ~$1.62 Float: ~50.9M Short Float: ~0.9%
0 · Reply
focafoca99
focafoca99 Sep. 7 at 11:16 PM
$NYXH announced its first patient implanted in the U.S. BREATHE study of the Genio system.
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 7 at 9:53 PM
$NYXH Larger float here... Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System "today announced that the first patient has been implanted in BREATHE, the Company’s U.S. post-approval study of the Genio® system."
0 · Reply
Noobnr1
Noobnr1 Sep. 6 at 5:30 AM
$NYXH Hello we are so underrated, helping lots of people for a better sleep. Going to be a huge business, expanding well $GILD $PFE $OMER
0 · Reply
Lilingpeace
Lilingpeace Sep. 3 at 10:06 PM
$NYXH Gemini says:
0 · Reply
topstockalerts
topstockalerts Sep. 3 at 8:44 PM
Nyxoah SA said its pivotal U.S. ACCCESS study met its primary safety and efficacy endpoints in patients with Complete Concentric Collapse. The medtech company reported a 77.2% Apnea-Hypopnea Index response rate and no serious device-related adverse events over 12 months. The Genio system was evaluated in patients with Complete Concentric Collapse of the soft palate, a population currently contraindicated for commercially available unilateral hypoglossal nerve stimulation in the U.S. At 12 months, the study showed a 77.2% AHI response rate, meeting Sher criteria, while the Oxygen Desaturation Index response rate reached 78.7%. The primary analysis included 47 patients who were implanted, activated and completed at least one sleep study. Enrollment was completed in August 2025 ahead of the planned maximum of 106 patients. $NYXH
0 · Reply
topstockalerts
topstockalerts Sep. 3 at 2:17 PM
Top Gainers PT2 $AEHL $BIAF $SNOW $NYXH $LHAI
0 · Reply
GTMStox
GTMStox Sep. 3 at 2:04 PM
$NYXH Grade A POS
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Sep. 3 at 1:20 PM
🌅 Watchlist part 2 ✅ $TLYS low 5 support, above 5.30, potential to 5.60/.80 ✅ $NYXH 1.80 support, ideal if above 2; above 2.10, potential to 2.50/.60 ✅ $UFG .60 support, above .80, potential to 1/1.30 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $CAST $FRTT still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
alecsalaur198
alecsalaur198 Sep. 3 at 1:16 PM
$NYXH 2+
0 · Reply
basti22
basti22 Sep. 3 at 12:57 PM
$NYXH
0 · Reply
OpenOutcrier
OpenOutcrier Sep. 3 at 12:52 PM
$NYXH (+15.9% pre) NYXH Stock Jumps As ACCCESS Trial De-Risks U.S. Growth Story https://ooc.bz/l/113163
0 · Reply
Merlintrader
Merlintrader Sep. 3 at 12:44 PM
Nyxoah ($NYXH) Stock Hub 2026: ACCCESS Meets Both Primary Endpoints With a 77.2% Responder Rate, Opening the U.S. Door to CCC Patients https://www.merlintrader.com/nyxoah-nyxh-stock-hub/
0 · Reply
briefingcom
briefingcom Sep. 3 at 12:17 PM
$NYXH: Nyxoah S.A. (+12.5%) announces ACCESS U.S. pivotal study met primary safety and efficacy endpoints in complete concentric collapse patients.
0 · Reply
Mr_GAAAAHDAMMMN
Mr_GAAAAHDAMMMN Sep. 3 at 9:09 AM
$NYXH how is this not popping!
0 · Reply
basti22
basti22 Sep. 3 at 8:40 AM
$NYXH
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Sep. 3 at 4:07 AM
🌅 Watchlist part 1 ✅ $GPRO 1.65 support, above 2, potential to 2.3/.5 ✅ $GIPR .5 support, above .8, potential to 1/1.4 ✅ $GELS ideal if above 1.05, above 1.3, potential to 1.7/.8 ✅ $TLYS low 5 support, above 5.3, potential to 5.6/.8 ✅ $NYXH 1.8 support, ideal if above 2, above 2.1, potential to 2.5/.6 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 3 at 3:03 AM
Updated gappers in after hours trading $GELS $GIPR $TLYS $NYXH $UFG Enjoy your evening!
0 · Reply
topstockalerts
topstockalerts Sep. 3 at 2:04 AM
$NYXH this might sneak up on people if it keeps going
0 · Reply
DayTrade_4Life
DayTrade_4Life Sep. 3 at 1:58 AM
💵Some Stocks to Watch for 3 Sept: $GIPR $GELS $NYXH $TLYS $UFG GPRO LHAI VIOT BIAF NCPL 🔥Below are results from today and last month's Top Alerts. 👉See link in profile to Join Us.
0 · Reply
XkaliburTrading
XkaliburTrading Sep. 3 at 1:35 AM
I hope you all had an amazing day today. Whether you made the most of the opportunities the market gave you or walked away with a valuable lesson, every day is another step forward. I'm already excited for tomorrow and putting together the watchlist for the team. We'll be locked in, prepared, and ready to fire on all cylinders when the market opens. Have a great evening, get some rest, and let's do it all again tomorrow. LFG, XKALIBUR TRADING Team! 🔥📈 $GIPR $GELS $TLYS $NYXH $GPRO
0 · Reply